Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chondroitin sulfate for interstitial cystitis.

E Palylyk-Colwell

    Issues in Emerging Health Technologies
    |May 27, 2006
    PubMed
    Summary

    Chondroitin sulfate solution, a glycosaminoglycan (GAG) therapy, shows potential for interstitial cystitis (IC) patients. Further head-to-head trials are needed to confirm its effectiveness against other IC treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Rituximab for rheumatoid arthritis.

    Issues in emerging health technologies·2006
    Same author

    CYP450 genotyping for determining drug metabolizer status.

    Issues in emerging health technologies·2006
    Same author

    State of Pharmaceutical Research and Development in Canada. Bioequivalence of Drug Products with Special Characteristics. Report of the February 13-14, 1998 Canadian Society for Pharmaceutical Sciences Symposium.

    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques·2000
    Same author

    Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion.

    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques·2000

    Area of Science:

    • Urology
    • Biochemistry

    Background:

    • Interstitial cystitis (IC) is a chronic condition affecting bladder function.
    • Glycosaminoglycan (GAG) replenishment therapy aims to restore the bladder's protective layer.
    • Chondroitin sulfate solution 2.0% is a GAG therapy for GAG-deficient patients with IC.

    Purpose of the Study:

    • To evaluate the potential of chondroitin sulfate solution as a therapy for interstitial cystitis.
    • To summarize findings from pilot studies on chondroitin sulfate for IC symptoms.

    Main Methods:

    • Review of two non-randomized, uncontrolled pilot studies.
    • Analysis of patient-reported symptoms following one year of chondroitin sulfate instillation.

    Main Results:

    • Pilot studies indicated improvements in patient-reported symptoms.
    • The therapy is currently low-cost with low demand.

    Conclusions:

    • Chondroitin sulfate shows promise for IC symptom management.
    • Prospective, randomized, head-to-head trials are necessary to compare its efficacy with existing IC therapies.
    • Increased adoption could impact clinical practice significantly.

    Related Experiment Videos